Aurora Sponsors Cannabis Amnesty to Support Next Phase of Cannabis Advocacy
EDMONTON, AB, Nov. 22, 2021 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a renewed sponsorship of Cannabis Amnesty in support of their advocacy work, calling for blanket pardons to all individuals for the offence of simple possession of cannabis. The sponsorship will support Cannabis Amnesty's campaign to right these historical wrongs – especially the impact on racialized communities.
Over half a million Canadians still have criminal records for simply possessing cannabis; creating barriers to meaningful work, volunteering, and travel.
"As a proudly Canadian company, Aurora values our roots in advocating for cannabis record pardons with Cannabis Amnesty," says Miguel Martin, CEO. "We have a responsibility to those communities who have been disproportionately impacted. Canadians, or anyone for that matter, shouldn't be burdened with a criminal record for a minor, non-harmful act that is no longer a crime."
The $50,000 contribution from Aurora will enable Cannabis Amnesty to enhance their operations, facilitating their ability to directly engage with and support communities harmed by cannabis prohibition. A portion of the funds will go toward the hiring of Cannabis Amnesty's first full-time staff member, in collaboration with TOQi Technologies Ltd., to lead the next phase of cannabis advocacy. This includes calling for pardons and cannabis record expungement with a focus on the disproportionate criminal records still held by racialized communities in Canada and working in the community to provide pardon resources directly to individuals.
"Aurora's Cannabis Amnesty sponsorship demonstrates leadership within the cannabis industry, taking a step forward to address the social inequities of cannabis prohibition," says Annamaria Enenajor, Founder of Cannabis Amnesty. "Cannabis Amnesty looks forward to working with Aurora to help influence policy for the better, and continue the call for cannabis record expungement here in Canada.
About Cannabis Amnesty:
Cannabis Amnesty is an independent, not-for-profit advocacy group focused on righting the historical wrongs caused by decades of cannabis prohibition, particularly its impact on racialized communities. It was founded in April 2018, in response to the absence of federal legislation addressing the stigma of previous convictions for offences that would no longer be illegal under the Cannabis Act. Since then, they have campaigned for the government to enact legislation to delete criminal records relating to the simple possession of cannabis, launched public education campaign to fight the stigma associated with cannabis convictions and worked on criminal justice reform to make sure that the legal structures that allowed marginalized communities to be overrepresented in cannabis prosecutions are dismantled. Visit www.cannabisamnesty.ca for more information.
Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn.
Aurora's common shares trade on the TSX and NASDAQ under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's renewed sponsorship of, and financial contribution to, Cannabis Amnesty and the anticipated associated impact on Cannabis Amnesty's operations and advocacy work.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 27, 2021 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.
Company Codes: NYSE:ACB, Toronto:ACB, NASDAQ-NMS:ACB
© 2021 PR Newswire. All Rights Reserved.